Tranilast (CAS 53902-12-8) – Anti-inflammatory API

Tranilast (CAS 53902-12-8) is a high-purity anti-inflammatory API with a unique mast cell stabilizer mechanism, delivering potent anti-allergic and anti-inflammatory effects. It inhibits the release of inflammatory mediators and regulates immune responses, targeting the root cause of inflammatory and allergic conditions. Manufactured under GMP-compliant processes, it ensures exceptional purity, stability, and bioactivity, meeting stringent global pharmaceutical standards.

This premium API is a vital raw material for pharmaceutical manufacturers developing medications for inflammatory and allergic disorders. It is widely applied in formulating drugs for asthma, allergic rhinitis, atopic dermatitis, and other immune-mediated conditions. With proven clinical safety and reliable efficacy, it caters to the growing demand for effective anti-inflammatory therapies. For pharmaceutical enterprises and research institutions, it offers a trusted, high-performance solution to advance treatments for inflammatory and allergic diseases.